A risk assessment model for gestational diabetes mellitus integrating maternal demographics and hematological indices in Thai women.
10 affiliations
- 1Environmental, Safety Technology and Health Program, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
- 2Office of Disease Prevention and Control Region 11, Nakhon Si Thammarat, Thailand.
- 3Department of Environmental Health, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
- 4Department of Occupational Health and Safety, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand.
- 5Excellence Center for Public Health Research, Walailak University, Nakhon Si Thammarat, Thailand.
- 6School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.
- 7Hematology and Transfusion Science Research Center, Walailak University, Nakhon Si Thammarat, Thailand.
- 8Center for Environmental and Health Sciences, Hokkaido University, Sapporo, Japan.
- 9Environmental, Safety Technology and Health Program, School of Public Health, Walailak University, Nakhon Si Thammarat, Thailand. [email protected].
- 10Excellence Center for Public Health Research, Walailak University, Nakhon Si Thammarat, Thailand. [email protected].
Abstract
Background
Universal screening for Gestational Diabetes Mellitus (GDM) is the gold standard, but it can be difficult and expensive in resource-limited settings. Many current prediction models rely on specialized tests that are not available in primary care. This study aimed to create a cost-effective risk assessment model using common maternal demographic and blood test data to help identify GDM risk in Thai pregnant women.Methods
We conducted a cross-sectional study with 200 pregnant women (24-28 weeks of gestation) at a secondary care hospital in Southern Thailand. We analyzed routine antenatal data, including complete blood count and other lab results. A risk-scoring system was built using multivariate logistic regression. We then tested the model's performance using Receiver Operating Characteristic (ROC) curve analysis to determine the optimal cut-off point.Results
Six independent predictors were found maternal age over 35 years, systolic blood pressure above 130 mmHg, glycosuria, hemoglobin at least 11 g/dL, platelets at least 260.50 × 10³/µL, and neutrophil-to-lymphocyte ratio (NLR) of 2.89 or higher. The combined risk model performed better (AUC = 0.804; 95% CI: 0.74-0.87) than single-marker models. With a risk score cut-off of 2.5 (indicating three or more risk factors), the model had a sensitivity of 71.4% and a specificity of 78.1%.Conclusion
The new risk assessment model, which uses basic demographic and routine blood test data, offers a reliable and affordable way to screen for GDM. This method enables early risk identification and helps healthcare providers use resources more efficiently, potentially reducing unnecessary tests in resource-limited settings.
Related
- Integrating probiotics into a one-day diabetes clinic: outcomes in gestational diabetes.
- The CKM–GDM multi-organ precision model: reframing gestational diabetes as an early cardiovascular–kidney–metabolic event in Southeast Asia
- A machine learning-based predictive model for gestational diabetes mellitus based on first trimester clinical indicators
- Maternity versus non‐maternity healthcare settings for the diagnosis of gestational diabetes or diabetes in pregnancy
- Pregnancy Complicated by Citrin Deficiency and Gestational Diabetes Mellitus: Perioperative Metabolic Management and Postoperative Analgesic Challenges Following Caesarean Delivery
BibTeX
@article{saiong2026risk,
title = {{A risk assessment model for gestational diabetes mellitus integrating maternal demographics and hematological indices in Thai women.}},
author = {Thaveesak Sai-Ong and Donrawee Waeyeng and Tanaporn Khamphaya and Yanisa Rattanapan and Chutima Jansakun and Atsuko Ikeda and Supabhorn Yimthiang},
journal = {BMC pregnancy and childbirth},
year = {2026},
month = jul,
doi = {10.1186/s12884-026-09608-x},
url = {https://europepmc.org/article/MED/42897525},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - A risk assessment model for gestational diabetes mellitus integrating maternal demographics and hematological indices in Thai women.
AU - Thaveesak Sai-Ong
AU - Donrawee Waeyeng
AU - Tanaporn Khamphaya
AU - Yanisa Rattanapan
AU - Chutima Jansakun
AU - Atsuko Ikeda
AU - Supabhorn Yimthiang
PY - 2026
DA - 2026/07/01
JO - BMC pregnancy and childbirth
DO - 10.1186/s12884-026-09608-x
UR - https://europepmc.org/article/MED/42897525
AB - Background Universal screening for Gestational Diabetes Mellitus (GDM) is the gold standard, but it can be difficult and expensive in resource-limited settings. Many current prediction models rely on specialized tests that are not available in primary care. This study aimed to create a cost-effective risk assessment model using common maternal demographic and blood test data to help identify GDM risk in Thai pregnant women.Methods We conducted a cross-sectional study with 200 pregnant women (24-28 weeks of gestation) at a secondary care hospital in Southern Thailand. We analyzed routine antenatal data, including complete blood count and other lab results. A risk-scoring system was built using multivariate logistic regression. We then tested the model's performance using Receiver Operating Characteristic (ROC) curve analysis to determine the optimal cut-off point.Results Six independent predictors were found maternal age over 35 years, systolic blood pressure above 130 mmHg, glycosuria, hemoglobin at least 11 g/dL, platelets at least 260.50 × 10³/µL, and neutrophil-to-lymphocyte ratio (NLR) of 2.89 or higher. The combined risk model performed better (AUC = 0.804; 95% CI: 0.74-0.87) than single-marker models. With a risk score cut-off of 2.5 (indicating three or more risk factors), the model had a sensitivity of 71.4% and a specificity of 78.1%.Conclusion The new risk assessment model, which uses basic demographic and routine blood test data, offers a reliable and affordable way to screen for GDM. This method enables early risk identification and helps healthcare providers use resources more efficiently, potentially reducing unnecessary tests in resource-limited settings.
SN - 1471-2393
ER -